M J Vos1, G S Mijnhout, J M M Rondeel, W Baron, P H P Groeneveld. 1. Departments of Clinical Chemistry (M.J.V., J.M.M.R.) and Internal Medicine (G.S.M., P.H.P.G.), Isala Hospital, 8025 AB Zwolle, The Netherlands; and Department of Cell Biology (W.B.), University of Groningen, University Medical Center Groningen, 9713 AV Groningen, The Netherlands.
Abstract
CONTEXT: SHBG is known as the major sex steroid binding protein in plasma, and it regulates the bioavailability of both T and estradiol levels required for effects on target tissues. We identified a man with an undetectable SHBG concentration in combination with low total T. He presented with a 7-year history of muscle weakness, fatigue, and a low libido. OBJECTIVES: To determine the cause of the SHBG deficiency, we employed both genetic analysis of the SHBG gene and transgene SHBG expression. RESULTS: Genetic analysis identified a novel homozygous missense mutation that was predicted to be deleterious for protein function. Transgene expression showed that the mutation resulted in a block in SHBG secretion accompanied by increased expression of the endoplasmic reticulum molecular chaperone HSPA5. The mutation results in accumulation of the mutant SHBG within the cell and failure to secrete the mutant protein. Screening of family members identified one sister who was also deficient for SHBG. CONCLUSIONS: We have identified a family with a missense mutation within the SHBG gene, which results in a complete deficiency of plasma SHBG in the homozygous state. Although total T level was low in the male patient, it did not interfere with normal gonadal development and spermatogenesis, suggesting a limited role of SHBG in sexual maturation and male physiology.
CONTEXT: SHBG is known as the major sex steroid binding protein in plasma, and it regulates the bioavailability of both T and estradiol levels required for effects on target tissues. We identified a man with an undetectable SHBG concentration in combination with low total T. He presented with a 7-year history of muscle weakness, fatigue, and a low libido. OBJECTIVES: To determine the cause of the SHBG deficiency, we employed both genetic analysis of the SHBG gene and transgene SHBG expression. RESULTS: Genetic analysis identified a novel homozygous missense mutation that was predicted to be deleterious for protein function. Transgene expression showed that the mutation resulted in a block in SHBG secretion accompanied by increased expression of the endoplasmic reticulum molecular chaperone HSPA5. The mutation results in accumulation of the mutant SHBG within the cell and failure to secrete the mutant protein. Screening of family members identified one sister who was also deficient for SHBG. CONCLUSIONS: We have identified a family with a missense mutation within the SHBG gene, which results in a complete deficiency of plasma SHBG in the homozygous state. Although total T level was low in the male patient, it did not interfere with normal gonadal development and spermatogenesis, suggesting a limited role of SHBG in sexual maturation and male physiology.
Authors: Karen Gjesing Welinder; Rasmus Hansen; Michael Toft Overgaard; Malene Brohus; Mads Sønderkær; Martin von Bergen; Ulrike Rolle-Kampczyk; Wolfgang Otto; Tomas L Lindahl; Karin Arinell; Alina L Evans; Jon E Swenson; Inge G Revsbech; Ole Frøbert Journal: J Biol Chem Date: 2016-09-08 Impact factor: 5.157
Authors: L Antonio; D Vanderschueren; N Narinx; K David; J Walravens; P Vermeersch; F Claessens; T Fiers; B Lapauw Journal: Cell Mol Life Sci Date: 2022-10-07 Impact factor: 9.207
Authors: Stine A Holmboe; Ravi Jasuja; Brian Lawney; Lærke Priskorn; Niels Joergensen; Allan Linneberg; Tina Kold Jensen; Niels Erik Skakkebæk; Anders Juul; Anna-Maria Andersson Journal: Endocr Connect Date: 2021-02 Impact factor: 3.335
Authors: Anna L Goldman; Shalender Bhasin; Frederick C W Wu; Meenakshi Krishna; Alvin M Matsumoto; Ravi Jasuja Journal: Endocr Rev Date: 2017-08-01 Impact factor: 25.261